Percheron Therapeutics (ASX:PER) - Key People
ASX:PER · Directors, executives and key personnel · 12 month lookback
Dr James Garner
Current
Chief Executive Officer and Managing Director
Mentioned in
Percheron Raises $2.2M as HMBD-002 Advances Toward Phase II Trial
30 Apr 2026
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
Percheron Therapeutics Cuts Losses, Advances Immuno-Oncology Asset HMBD-002
26 Feb 2026
Percheron Therapeutics Reports $14.9M Loss, Shifts Focus to Promising Oncology Asset
28 Aug 2025
Also Mentioned
People named in Percheron Therapeutics (ASX:PER) articles over the last 12 months, by frequency.
Charmaine Gittleson
· 5 articles
Ben Gil Price
· 3 articles
Professor Sudha R
· 1 article
Eugene Kennedy
· 1 article
Valentina Dubljevic
· 1 article
Deborah Ambrosini
· 1 article
George Tachas
· 1 article
Anthony Filippis
· 1 article